While large-scale, untargeted metabolomic studies remain relatively uncommon, there have been small-scale attempts to prove the applicability of this strategy
Wet AMD was diagnosed in 0.2% of GLP-1 users vs 0.1% of non-users
Similarly, FTO and MC4R variants correlate with baseline weight and metabolic resilience, potentially predicting treatment trajectory and durability
So, when you think about everything that's going on in the world today, including, which I'm sure we'll talk about, the relaxation of the leveraged lending guidelines, it was really fuel for private credit
Zachary Burns is a family medicine physician at the University of Rochester Medical Center, Associate Director of Moving Medicine Forward, and a partner of RLMI